Literature DB >> 2907546

Differences in the characteristics of opioid receptor binding in the rat and marmoset.

M Yeadon1, I Kitchen.   

Abstract

The density of mu and delta opioid binding sites in homogenates of rat and marmoset brain was determined using radiolabelled peptides with high receptor selectivity. In addition the affinity of mu and delta receptor binding of five drugs of the fentanyl series was measured. The ratio of mu: delta sites was similar within each species but the total receptor binding capacity in the rat was double that of the marmoset. The binding affinities for the delta site were dissimilar between the species and supports the hypothesis that the structure of this receptor shows phylogenetic differences. In contrast, mu site binding affinity was identical in rat and marmoset.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907546     DOI: 10.1111/j.2042-7158.1988.tb07008.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor.

Authors:  Bing Xie; Alexander Goldberg; Lei Shi
Journal:  Comput Struct Biotechnol J       Date:  2022-05-14       Impact factor: 6.155

2.  In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis.

Authors:  Sherif H Hassanien; Jonathon R Bassman; Carmelita M Perrien Naccarato; Jack J Twarozynski; John R Traynor; Donna M Iula; Jessica P Anand
Journal:  Drug Test Anal       Date:  2020-06-11       Impact factor: 3.345

Review 3.  Current Topics in Marmoset Anesthesia and Analgesia.

Authors:  Anna Goodroe; Casey Fitz; Jaco Bakker
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

4.  Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking.

Authors:  Christopher R Ellis; Naomi L Kruhlak; Marlene T Kim; Edward G Hawkins; Lidiya Stavitskaya
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

5.  Evaluating kratom alkaloids using PHASE.

Authors:  Christopher R Ellis; Rebecca Racz; Naomi L Kruhlak; Marlene T Kim; Alexey V Zakharov; Noel Southall; Edward G Hawkins; Keith Burkhart; David G Strauss; Lidiya Stavitskaya
Journal:  PLoS One       Date:  2020-03-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.